SENECA THERAPEUTICS

seneca-therapeutics-logo

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.

#SimilarOrganizations #People #Financial #Website #More

SENECA THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Life Science Pharmaceutical

Founded:
2018-01-01

Address:
Blue Bell, Pennsylvania, United States

Country:
United States

Website Url:
http://www.senecatherapeutics.com

Status:
Active

Contact:
484-883-9725

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Microsoft Azure DNS


Similar Organizations

biopep-solutions-logo

Biopep Solutions

Biopep Solutions is a biotechnology company that discovers and develops therapeutic products for the treatment of cancer and other diseases.

netnoids-rx-laboratories-logo

Netnoids Rx Laboratories

Netnoids Rx Laboratories uses patient-derived organoid model systems to help find a cure for rare cancers.

scisafe-logo

SciSafe

SciSafe is a biotechnology company that offers dedicated pharmaceutical and biological specimen storage in its state of the art facility.

Current Employees Featured

paul-hallenbeck_image

Paul Hallenbeck
Paul Hallenbeck CEO and Founder @ Seneca Therapeutics
CEO and Founder

Founder


paul-hallenbeck_image

Paul Hallenbeck

Investors List

mid-atlantic-bio-angels_image

Mid Atlantic Bio Angels

Mid Atlantic Bio Angels investment in Venture Round - Seneca Therapeutics

broad-street-angels_image

Broad Street Angels

Broad Street Angels investment in Venture Round - Seneca Therapeutics

Official Site Inspections

http://www.senecatherapeutics.com Semrush global rank: 6.57 M Semrush visits lastest month: 954

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Seneca Therapeutics"

Our Team - Seneca Therapeutics Therapeutics

Prior to joining Seneca Therapeutics, Dr. Trinh was a consultant to the Department of U.S. Defense, WRAIR, and non-profit organization Henry M. Jackson Foundation to lead viral and โ€ฆSee details»

Seneca Therapeutics - Crunchbase Company Profile

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.See details»

Seneca Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Seneca Therapeutics, Inc. of Blue Bell, PA. Get the latest business insights from Dun & Bradstreet.See details»

Seneca Therapeutics, Inc. | LinkedIn

Seneca Therapeutics, Inc. Biotechnology Research Philadelphia, PA 483 followers Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients with solid cancersSee details»

Seneca Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

View Seneca Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Home โ€” Seneca Therapeutics Therapeutics

We believe a cure for cancer is within our lifetime and we are working with urgency to see this promising possibility become a reality. learn more ๏ปฟ๏ปฟSee details»

Seneca Therapeutics - PitchBook

Seneca Therapeutics General Information Description. Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. The company focuses on oncolytic immunotherapeutic candidates to synergize โ€ฆSee details»

Seneca Therapeutics, Inc. | Life Sciences PA

Www.senecatherapeutics.com; About. Seneca Therapeutics, Inc. (Seneca) is pursuing the development of an oncolytic immunotherapeutic called Seneca Valley Virus (SVV) and โ€ฆSee details»

Seneca Therapeutics - Products, Competitors, Financials, โ€ฆ

Senecatherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Debt - IV | Alive. Total Raised $6.45M. Last Raised $5M | 4 yrs ago. About Seneca โ€ฆSee details»

Seneca Therapeutics, Inc. | BioPharm America - Informa Connect

Seneca Therapeutics, Inc. (STI) was founded to develop the novel, clinically tested oncolytic Seneca Valley Virus (SVV) based on two key value drivers.See details»

Seneca Therapeutics, Inc. - Drug pipelines, Patents, Clinical

Seneca Therapeutics undertakes no obligation to update any forward-looking statements for any reason. www.senecatherapeutics.com. ... The statistics for drugs in the Pipeline is the current โ€ฆSee details»

Our Mission โ€” Seneca Therapeutics Therapeutics

Seneca Therapeutics, Inc. (Seneca) is developing a pipeline of novel cancer agents using the nonpathogenic Seneca Valley Virus isolate 001 (SVV-001).See details»

Seneca Therapeutics - VentureRadar

Auto Analyst Score: 37 | senecatherapeutics.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the โ€ฆSee details»

SVV-044 - Drug Targets, Indications, Patents - Synapse - Patsnap

Originator Organization. Seneca Therapeutics, Inc. Startup. Active Organization. Seneca Therapeutics, Inc. Startup. Inactive Organization-Drug ... Contacts Paul Hallenbeck โ€ฆSee details»

Seneca Therapeutics Receives FDA Clearance to Begin SVV-001 โ€ฆ

Oct 3, 2022 Paul Hallenbeck CSO and President [email protected]. James Hussey CEO [email protected]. www.senecatherapeutics.com. Contacts.See details»

Seneca Therapeutics โ€“ VisionTech Partners

Seneca Therapeutics is developing a pipeline of novel cancer agents using the nonpathogenic Seneca Valley Virus isolate 001 (SVV-001). The first product anticipated to be in later stage โ€ฆSee details»

Seneca Therapeutics, Inc. Receives Positive Feedback from FDA on ...

Sep 14, 2020 PHILADELPHIA--(BUSINESS WIRE)--Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immunotherapeutics for โ€ฆSee details»

Latest News โ€” Seneca Therapeutics Therapeutics

Nov 15, 2023 www.senecatherapeutics.com. Mason Duling. October 30, 2023. Seneca Therapeutics Garners Prestigious Recognition at Keiretsu Forumโ€™s Investor Capital Expo. โ€ฆSee details»

Eterna Therapeutics Changes Name to Ernexa Therapeutics to

1 day ago Ernexa Therapeutics embarks on new strategic direction, shifting the companyโ€™s focus from delivering a cell therapy platform to prioritizing product developmentSee details»

Dr. Paul Hallenbeck, CSO and President of Seneca Therapeutics to ...

Nov 27, 2023 www.senecatherapeutics.com. Contacts. Paul Hallenbeck CSO and President [email protected]. James Hussey CEO โ€ฆSee details»

linkstock.net © 2022. All rights reserved